Bluebird Bio

Just in time to assure a decision before CVR deadline, Bristol Myers Squibb files NDA for Celgene/bluebird CAR-T
Just in time to assure a decision before CVR deadline, Bristol Myers Squibb files NDA for Celgene/bluebird CAR-T
Endpoints
Bristol-Meyers Squibb
CAR-T
Celgene
ide-cel
Bluebird Bio
liso-cel
ozanimod
Flag link:
Bluebird says gene therapy application delayed again, citing disagreement with FDA
Bluebird says gene therapy application delayed again, citing disagreement with FDA
BioPharma Dive
Bluebird Bio
LentiGlobin
FDA
Flag link:
Why AnaptysBio, bluebird bio, and Exelixis Shares Rebounded Last Friday
Why AnaptysBio, bluebird bio, and Exelixis Shares Rebounded Last Friday
Motley Fool
pharma stocks
AnaptysBio
Bluebird Bio
Exelixis
COVID-19
Flag link:
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
Flag link:
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Bluebird Bio
earnings
Flag link:
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
Fierce Biotech
CAR-T
Multiple Myeloma
CD229
JNJ
Bluebird Bio
Flag link:
5 biopharmas to watch as the decade's last earnings kick off
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
earnings
Novartis
Biogen
Eli Lilly
Global Blood Therapeutics
Bluebird Bio
Flag link:
Who are the 10 Most Innovative Biopharma Companies?
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Flag link:
LentiGlobin gene therapy for sickle cell on course for filing, says bluebird
LentiGlobin gene therapy for sickle cell on course for filing, says bluebird
Pharmaforum
LentiGlobin
Bluebird Bio
sickle cell disease
Flag link:
Myeloma cell therapies, now in pharma hands, move into spotlight
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
ASH2019
cell therapies
Multiple Myeloma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
Flag link:
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Flag link:
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
gene therapy
drug manufacturing
Pfizer
Novartis
Bluebird Bio
PTC Therapeutics
Krystal Biotech
Flag link:
Bluebird gets European green light for gene therapy production
Bluebird gets European green light for gene therapy production
Biopharma Dive
Bluebird Bio
gene therapy
Europe
Zynteglo
Flag link:
Why Novo Nordisk should buy Uniqure
Why Novo Nordisk should buy Uniqure
EP Vantage
Novo Nordisk
gene editing
hemophilia
uniQure
Bluebird Bio
Flag link:
Novo taps bluebird bio for gene-editing tech
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Novo Nordisk
Bluebird Bio
R&D
gene editing
hemophilia
Flag link:
bluebird presents long-term data from CALD gene therapy
bluebird presents long-term data from CALD gene therapy
Pharmaforum
Bluebird Bio
gene therapy
cALD
Lenti-D
Flag link:
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Flag link:
bluebird bio Prepares for Launch
bluebird bio Prepares for Launch
Motley Fool
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
Flag link:
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Yahoo/Zacks.com
Bluebird Bio
earnings
Flag link:
Where Will bluebird bio Be in 1 Year?
Where Will bluebird bio Be in 1 Year?
Motley Fool
Bluebird Bio
bb2121
Zynteglo
Flag link:

Pages